UCA1 down-regulation increased the tamoxifen sensitivity through inhibiting Wnt/β-catenin pathway in breast cancer cells while UCA1 up-regulation promoted EMT of breast cancer cells by activating Wnt/β-Catenin signaling pathway [31,52]. The gene discussed is UCA1; the disease is breast cancer.